SCHEMBL8637907

SCHEMBL8637907

CN1CCN(CCN2CCC(c3cn(-c4ccc(F)cc4)c4ccc(C(F)(F)F)cc34)CC2)C1=O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.59
HTR1B P28222 3/20 0.59
DRD2 P14416 2/20 0.59
HTR2C P28335 2/20 0.59
HRH1 P35367 2/20 0.59
DRD4 P21917 2/20 0.59
DRD3 P35462 2/20 0.59
MLNR O43193 1/20 0.59
CACNA1F O60840 1/20 0.59
NR1I2 O75469 1/20 0.59
ABCB11 O95342 1/20 0.59
ABCB1 P08183 1/20 0.59
ADRB1 P08588 1/20 0.59
ADRA2A P08913 1/20 0.59
ADORA3 P0DMS8 1/20 0.59
CHRM1 P11229 1/20 0.59
ADRA2B P18089 1/20 0.59
ADRA2C P18825 1/20 0.59
CHRM3 P20309 1/20 0.59
MAOA P21397 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8640368 0.90 MLNR (0.55) HTR1AHTR1BDRD2HTR2CHRH1
SCHEMBL8640730 0.88 KCNH2 (0.75) HTR1AHTR1BDRD2HTR2CHRH1
SCHEMBL8640470 0.86 HTR1A (0.79) HTR1AHTR1BDRD2HTR2CHRH1
SCHEMBL8635736 0.86 HTR1A (0.59) HTR1AHTR1BDRD2HTR2CHRH1
SCHEMBL9150260 0.83
SCHEMBL9122834 0.81 DRD2 (0.67) HTR1BDRD2HTR2AHTR6KCNH2
SCHEMBL8638021 0.81 MLNR (0.59) HTR1AHTR1BDRD2HTR2CHRH1
SCHEMBL8295653 0.79 KCNH2 (0.75) HTR1AHTR1BDRD2HTR2CHRH1
SCHEMBL9120920 0.79 KCNH2 (0.75) HTR1AHTR1BDRD2HTR2CHRH1
SCHEMBL8302277 0.79 KCNH2 (0.71) HTR1AHTR1BDRD2HTR2CHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575430-B1 PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ADDICTION TO DRUGS AND SUBSTANCES OF ABUSE LUNDBECK & CO AS H (DK) 1998-08-05 EP disclosed
EP-0575429-B1 TREATMENT OF COGNITIVE DISORDERS LUNDBECK & CO AS H (DK) 1995-12-06 EP disclosed
US-5462948-A Treatment of addiction to drugs and substances of abuse H. LUNDBECK A/S (DK) 1995-10-31 US disclosed
US-5444073-A Administering 1-aryl-3-(4-piperidyl)-indole derivatives H. LUNDBECK A/S (DK) 1995-08-22 US disclosed
US-5439922-A Administering dopamine antagonists having reduced side effects H. LUNDBECK A/S (DK) 1995-08-08 US disclosed
EP-0533824-B1 PIPERIDYL-SUBSTITUTED INDOLES LUNDBECK & CO AS H (DK) 1994-11-09 EP disclosed